Reforming 340B: Ensuring the Discount Program Delivers for Patients скачать в хорошем качестве

Reforming 340B: Ensuring the Discount Program Delivers for Patients

On December 12th, ASBM and the Global Colon Cancer Association (GCCA) hosted a one-hour webinar discussing the 340B Drug Discount Program, a federal program designed to help hospitals and clinics serving patients in need. The webinar, entitled "Reforming 340B: Ensuring the Discount Program Delivers for Patients" discussed how the program has strayed from its original mission- becoming a profit center for large, wealthy health systems. Presenters discussed the history and evolution of the program, highlighted current challenges, and examined bipartisan reform efforts underway in Congress to restore the program to its original mission.  Expert panelists included: Thomas Barker; Former Deputy General Counsel, US Department of Health and Human Services Madelaine Feldman, MD FACR; VP of Advocacy and Government Affairs, Coalition of State Rheumatology Organizations (CSRO) Kathy Oubre, CEO, Ponchartrain Cancer Center Michael Reilly; ASBM Executive Director, former Associate Deputy Secretary of the U.S. Dept. of Health and Human Services  Andrew Spiegel; Executive Director of the Global Colon Cancer Association